Please assess the completion status of the following clinical trial:

Trial Title: Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Positive IgG result for toxoplasmosis (IgG)~* Ipsilateral scars of retina compatible with previous episode of toxoplasmosis retinochoroiditis~* Unilateral active lesion of chorioretinitis~Exclusion Criteria:~* Under 18 years of age~* Immunosuppressed patients~* Use of immunosuppressive treatments~* Concomitant chorioretinitis of other causes~* Pregnancy~* Allergy to Sulfonamides

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Trimethoprim-Sulfamethoxazole (Type: ACTIVE_COMPARATOR): 1 tablet every other day, morning.
- Starch tablet (Type: PLACEBO_COMPARATOR): 1 starch tablet every other day, morning.

Based on this trial design, predict the completion outcome and termination type (if applicable).